Trade Names: | |
Synonyms: | |
Status: | Approved (1957) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | B01AA04 |
UNII: | Q08SIO485D |
InChI Key | QNDUUBVQYBBRBW-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C18H16O3 |
Molecular Weight | 280.32 |
AlogP | 4.04 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 50.44 |
Molecular species | ACID |
Aromatic Rings | 3.0 |
Heavy Atoms | 21.0 |
Primary Target | |
---|---|
vitamin K epoxide reductase complex subunit 1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | - | - | 200 | - | |
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
- | 1000 | - | 1-1000 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Venous Thrombosis | 3 | D020246 | ClinicalTrials |
Venous Thrombosis | 3 | D020246 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 435-97-2 |
ChEBI | 50438 |
ChEMBL | CHEMBL1465 |
DrugBank | DB00946 |
DrugCentral | 2138 |
EPA CompTox | DTXSID5023459 |
FDA SRS | Q08SIO485D |
Human Metabolome Database | HMDB0015081 |
Guide to Pharmacology | 6839 |
KEGG | D05457 |
PubChem | 54680692 |
SureChEMBL | SCHEMBL43031 |
ZINC | ZINC03876174 |